I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Špicka, Ivan
106
results:
OpenAccess-fulltext X
Search for persons
X
Sorted by: Relevance
Sorted by: Year
?
1
P1294: REAL-WORLD OUTCOMES OF 2149 NEWLY DIAGNOSED TRANSPLA..:
Popková, Tereza
;
Pour, Ludek
;
Spicka, Ivan
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430534/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
2
Isatuximab, carfilzomib, and dexamethasone in patients with..:
Martin, Thomas
;
Dimopoulos, Meletios-Athanasios
;
Mikhael, Joseph
...
https://discovery.ucl.ac.uk/id/eprint/10169728/1/s41408-023-00797-8.pdf. , 2023
Link:
https://discovery.ucl.ac..
?
3
Isatuximab, carfilzomib, and dexamethasone in patients with..:
Martin, Thomas
;
Dimopoulos, Meletios-Athanasios
;
Mikhael, Joseph
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166682/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
4
Clinical characteristics and outcomes in risk-stratified pa..:
Sandecka, Viera
;
Popkova, Tereza
;
Stork, Martin
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522616/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
5
Daratumumab with lenalidomide and dexamethasone in relapsed..:
Stork, Martin
;
Spicka, Ivan
;
Radocha, Jakub
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10182121/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
6
P968: ALLOCATION AND VALIDATION OF THE SECOND REVISION OF T..:
Perrot, Aurore
;
Richardson, Paul
;
Mikhael, Joseph
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431483/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
7
Personalised progression prediction in patients with monocl..:
Cowan, Annie
;
Ferrari, Federico
;
Freeman, Samuel S
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9991855/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
8
Correction: Isatuximab, carfilzomib, and dexamethasone in p..:
Martin, Thomas
;
Dimopoulos, Meletios-Athanasios
;
Mikhael, Joseph
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522597/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
9
P916: LONG-TERM OUTCOMES WITH ISATUXIMAB-CARFILZOMIB-DEXAME..:
Facon, Thierry
;
Moreau, Philippe
;
Špicka, Ivan
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431030/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
10
Daratumumab with lenalidomide and dexamethasone in relapsed..:
Štork Martin
;
Spicka Ivan
;
Radocha Jakub
...
https://is.muni.cz/publication/2278163. , 2023
Link:
https://is.muni.cz/publi..
?
11
Personalised progression prediction in patients with monocl..:
Cowan, Annie
;
Ferrari, Federico
;
Freeman, Samuel S
...
https://discovery.ucl.ac.uk/id/eprint/10166157/1/1-s2.0-S2352302622003866-main.pdf. , 2023
Link:
https://discovery.ucl.ac..
?
12
P944: REAL-WORLD PATIENT CHARACTERISTICS AND SURVIVAL OUTCO..:
Spicka, Ivan
;
Lapidot, Ido
;
Merz, Maximilian
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431474/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
13
Addition of elotuzumab to lenalidomide and dexamethasone fo..:
Dimopoulos, Meletios A
;
Richardson, Paul G
;
Bahlis, Nizar J
...
info:eu-repo/semantics/altIdentifier/pmid/35550060. , 2022
Link:
https://hdl.handle.net/2..
?
14
Anti-CD38 antibody therapy for patients with relapsed/refra..:
Leleu, Xavier
;
Martin, Thomas
;
Weisel, Katja
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9463192/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
15
Antibody interference and response kinetics of isatuximab p..:
Hulin, Cyrille
;
Beksac, Meral
;
Goodman, Hugh J
...
Blood cancer journal. , 2022
Link:
http://hdl.handle.net/10..
1-15
